The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial

By Qu Yongming   Wong Mayme   Thiebaud Daniel   Stock John L.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1955-1959

Informa Healthcare

Access to resources Recommend Favorite

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis – a clinical update on efficacy and safety

By Deal Chad L   Draper Michael W  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 199-210

Future Medicine

Access to resources Recommend Favorite

Epidemiology and clinical features of Shewanella infection over an eight-year period

By To Kelvin K. W.   Wong Samson S. Y.   Cheng Vincent C. C.   Tang Bone S. F.   Li Iris W. S.   Chan Jasper F. W.   Seto Wai-Kay   Tse Herman   Yuen Kwok-Yung  

Scandinavian Journal of Infectious Diseases, Vol. 42, Iss. 10, 2010-10 ,pp. : 757-762

Informa Healthcare

Access to resources Recommend Favorite

Trospium chloride: over 20 years of clinical use

By Sand Peter K  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 215-226

Future Medicine

Access to resources Recommend Favorite

Clinical Pharmacists Prescribing Drug Therapy in a Geriatric Setting: Outcome of a Trial

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 32, Iss. 2, 1984-02 ,pp. : 154-159

John Wiley & Sons Inc

Access to resources Recommend Favorite